Pet Vaccine Market
完整報告名稱與涵蓋範圍
Pet Vaccine Market Size, Share & Trends Analysis Report, Animal Type (Canine, Feline and Equine), By Mode of Administration (Injectable, Intranasal, and Others)), By Vaccine Type, By Region, Forecasts, 2025-2034
報告摘要
The worldwide Pet Vaccine Market stood at USD 11.7 Bn in 2024, and is set to reach USD 23.1 Bn by 2034, recording a CAGR of 7.4% from 2025 through 2034.
Pet Vaccine covers reshaping how healthcare entities approach this space.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the escalating emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Pet Vaccine Market Snapshot
Chapter 4. Global Pet Vaccine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Pet Vaccine Market Industry Trends
4.10. Global Pet Vaccine Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Pet Vaccine Market Segmentation 1: By Animal Type, Estimates & Trend Analysis
5.1. Market Share By Animal Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product Type:
5.2.1. Canine
5.2.2. Feline
5.2.3. Equine
Chapter 6. Pet Vaccine Market Segmentation 2: By Vaccination, Estimates & Trend Analysis
6.1. Market Share By Vaccination, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Source:
6.2.1. Canine Family
6.2.2. Feline Family
6.2.3. Others
Chapter 7. Pet Vaccine Market Segmentation 3: By Mode Of Administration, Estimates & Trend Analysis
7.1. Market Share By Mode Of Administration, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Animal Type:
7.2.1. Injectable Vaccines
7.2.2. Intranasal Vaccines
Chapter 8. Pet Vaccine Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. Global Pet Vaccine Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Animal Type, 2021-2034
8.2.3. North America Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Vaccination, 2021-2034
8.2.4. North America Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Mode Of Administration, 2021-2034
8.3. Europe
8.3.1. Europe Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Animal Type, 2021-2034
8.3.3. Europe Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Vaccination, 2021-2034
8.3.4. Europe Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Mode Of Administration, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Animal Type, 2021-2034
8.4.3. Asia Pacific Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Vaccination, 2021-2034
8.4.4. Asia Pacific Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Mode Of Administration, 2021-2034
8.5. Latin America
8.5.1. Latin America Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Animal Type, 2021-2034
8.5.3. Latin America Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Vaccination, 2021-2034
8.5.4. Latin America Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Mode Of Administration, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Animal Type, 2021-2034
8.6.3. Middle East & Africa Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Vaccination, 2021-2034
8.6.4. Middle East & Africa Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Mode Of Administration, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Bayer AG
9.2.1.1. Business Overview
9.2.1.2. Key Product Type/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Elanco US Inc.
9.2.3. Merck KGaA
9.2.4. Merial Inc.
9.2.5. Virbac SA
9.2.6. Zoetis Inc
9.2.7. Phibro Animal Health Corporation
9.2.8. Boehringer Ingelheim GmbH
9.2.9. Tianjin Ringpu Bio-Technology Co., Ltd
9.2.10. Vetoquinol SA
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們